Here’s how much house you can buy in Houston for $250,000

H-TOWN VALUE

Austin offers the least bang for your buck among Texas' major metro areas. Photo by Ariel Skelley/Getty Images

Houston may be in the midst of a pandemic, but that hasn't slowed our real estate market. And a new study shows just how much bang for your buck you can get in the Bayou City versus Texas' other major metro areas.

A study released July 7 by the PropertyShark real estate website shows that $250,000 will get Houston buyers a 2,318 square-foot-house, which works out the second-best value in Texas.

In the Houston metro area, last year's sales of single-family homes totaled 90,145, up 3.6 percent from 2018, according to the Texas Association of Realtors.

"Townhomes and condominiums had a roller coaster ride and the luxury market cooled a bit, but overall, 2019 was a phenomenal year," John Nugent, 2020 chairman of the Houston Association of Realtors, said in a January release.

For some comparison, $250,000 nets Austin buyers a 1,139-square-foot house — the least amount among Texas' biggest cities. PropertyShark's data includes single-family homes, duplexes, condos, and townhouses.

In its report on the 2019 real estate market, the Austin Board of Realtors noted that median home price in the region rocketed from $193,520 in 2010 to $318,000 in 2019. The Texas Association of Realtors says 36,782 single-family homes were sold in the Austin metro area last year.

"If we don't take action to increase housing supply in Austin, we will continue to see exponential increases in home values," Romeo Manzanilla, 2020 president of the Austin Board of Realtors, warned in a January release.

While Austin's position in the PropertyShark study is worse than every other big city in Texas, it's considerably better than places like New York City, San Francisco, and Los Angeles. In Manhattan, $250,000 would enable you to buy a home the size of a hotel room — 232 square feet. The situation isn't much better in San Francisco, where $250,000 would get you a 269-square-foot home. In Los Angeles, that dollar amount would let you purchase a 524-square-foot home.

"In the country's most populated cities with more than 900,000 residents, the difference in price per square foot between coastal cities and Texas cities is miles apart," PropertyShark notes. "As expected, vast Texas leads the way in providing the most space for the lowest price. In fact, in every Texas city we analyzed, $250,000 will buy more than 1,000 square feet."

San Antonio, meanwhile, continues to solidify its status as the most affordable housing market among major Texas cities. According to the study, a buyer spending $250,000 could purchase a 2,503-square-foot home in San Antonio. That amounts to $100 per square foot.

Looking at the country's 100 largest cities, San Antonio ranks 15th for the amount of square footage available for $250,000. Detroit sits atop the list. There, you can buy a 5,407-square-foot home for $250,000, PropertyShark says.

Last year, 35,456 single-family homes were sold in the San Antonio metro area, according to the Texas Association of Realtors. That's a 6 percent increase compared with 2018. Homes priced between $200,000 and $500,000 made up more than half of the region's sales volume in 2019.

"San Antonio continues to be a top destination for both buyers and sellers, and it's exciting to see such tremendous growth in people achieving their dreams of homeownership," Kim Bragman, 2020 chairwoman of the San Antonio Board of Realtors, said in a January release.

Looking at the country's 100 largest cities, San Antonio ranks 15th for the amount of square footage available for $250,000. Detroit sits atop the list. There, you can buy a 5,407-square-foot home for $250,000, PropertyShark says.

Here's how all the cities in Texas' four largest metro areas compared when it comes to the amount of space you can score for $250,000:

  • Houston, 2,318 square feet
  • San Antonio, 2,503 square feet
  • Arlington, 2,240 square feet
  • Garland, 2,218 square feet
  • Fort Worth, 2,109 square feet
  • Irving, 2,072 square feet
  • Dallas, 1,722 square feet
  • Plano, 1,657 square feet
  • Austin, 1,139 square feet

Like San Antonio and Austin, Houston and Dallas-Fort Worth enjoyed robust home sales volume in 2019.

In Dallas-Fort Worth, single-family home sales totaled 103,261 last year, up 3 percent from 2018, the Texas Association of Realtors says.

"Dallas-Fort Worth winds up with record sales again," James Gaines, chief economist at Texas A&M University's Real Estate Center, said in January. "The Dallas side of the Metroplex was actually a little better than Fort Worth."

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

4 Houston-area institutions get $8M for cancer research facilities

fighting cancer

Cancer research capabilities in the Houston area just got an $8 million boost.

On Wednesday, May 20, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded $8 million in grants to institutions in Houston and Bryan for the creation or expansion of so-called “core” cancer research facilities.

“Core facilities provide shared access to advanced technology, equipment, and scientific expertise that may not be available at every institution,” CPRIT says. “These core facilities are vital to not only cancer research but also to the study of diseases beyond cancer.”

Houston-area recipients of these $2 million grants are:

  • A facility at the University of Texas Health Science Center for preclinical support of cancer researchers in Texas to evaluate new safe, effective drugs and drug combinations.
  • The Accelerator for Cancer Therapeutics, operated by Houston’s Texas Medical Center Foundation. The accelerator helps researchers and startups move innovative cancer treatments from the lab to clinical trials.
  • Rice University’s Genetic Design & Engineering Center in Houston. The center enables researchers to collaborate on studies of custom DNA for cancer treatment.
  • A facility at the Texas A&M University System’s Health Science Center in Bryan that aims to speed up the development of cancer therapies.

In addition to those grants, the University of Texas M.D. Anderson Cancer Center, Methodist Hospital Research Institute, Baylor College of Medicine, and Rice University shared $21 million to recruit cancer researchers from other institutions.

The largest of those grants—totalling $4 million—went to M.D. Anderson for the recruitment of renowned cancer researcher Andre Nussenzweig from the National Institutes of Health. His research focuses on how DNA damage and faulty DNA repairs lead to cancer.

Here are the totals for the other CPRIT grants awarded in the Houston area:

  • $12.8 million to Houston-based Indapta Therapeutics for the development of an off-the-shelf therapy that naturally kills cancer cells, combined with an immunity-targeting agent for a type of leukemia.
  • $11.1 million to MD Anderson, including $5 million for a statewide platform to improve long-term health outcomes in adolescents and young adults who survived cancer.
  • $8.4 million to Baylor College of Medicine, including $4.8 million for two training programs for cancer researchers.
  • $6.25 million to UT Health Houston, including $4 million for a biomedical informatics and genomics training program for cancer researchers.
  • $4.4 million to the Texas A&M Health Science Center’s Houston campus, including $2.4 million for a cancer therapeutics training program.
  • $2.75 million to Rice, including $250,000 for a study of ovarian cancer.
  • $2 million to Houston-based March Biosciences for the development of a targeted therapy for treating T-cell lymphoma.
  • $1.15 million to the University of Houston, including $900,000 for a platform for detection of lung cancer.
  • $900,000 to Texas A&M in Bryan to conduct clinical drug trials in rural and underserved communities around the state.
  • $800,000 to Houston- and Israel-based Xerient Pharma for the development of an oral form of a cell-protecting drug called amifostine to protect the upper GI tract from radiation damage during pancreatic cancer treatment.
  • $659,000 to Missouri City-based OmniNano Pharmaceuticals for the development of a two-drug combination to treat the most common form of pancreatic cancer.
  • $250,000 to the University of Texas Medical Branch at Galveston for a novel therapeutic to prevent colitis-related colorectal cancer.

Axiom Space launches Japanese subsidiary, names leadership

Axiom Space is setting up a Japanese subsidiary to tap into billions of dollars worth of business opportunities in the vast Asia-Pacific region. The company’s new office in Japan will open July 1.

“For the Asia-Pacific region, an Axiom Space presence in Japan means a long-term, direct path to low-Earth orbit for research, for industry, for astronauts, and a partner committed to building that future together with Japan,” Jonathan Cirtain, president and CEO of Axiom Space, said in a news release.

Asia-Pacific spaceflight leaders include Japan, China, India and South Korea.

Until committing to the Asia-Pacific subsidiary, Axiom focused primarily on the U.S. market for space exploration equipment, technology and services. Axiom is building the successor to the International Space Station (ISS), and it provides human spaceflight services and develops next-generation spacesuits.

Fortune Business Insights estimates the Asia-Pacific market for space technology was valued at $155.3 billion in 2025.

“The region is rapidly expanding due to rapidly expanding government space programs, increasing private sector participation, and rising demand for satellite services across densely populated regions,” says Fortune Business Insights, a market research firm.

The region’s combination of strategic investments, market demand and emerging entrepreneurial systems positions Asia-Pacific “for the fastest growth in the global market,” Fortune Business Insights says.

The market research firm pegs the U.S. market for space technology at $251.8 billion in 2025, making it the world’s largest player in that sector.

Veteran Japanese astronaut Koichi Wakata will lead Axiom Space Japan as chief technology officer in the Asia-Pacific region. The Japanese subsidiary will work with government agencies, research institutions, and industrial partners in Japan to expand hardware development and manufacturing, microgravity research and orbital computing.

Wakata was the Japanese space agency’s first program manager for ISS and the station’s first Japanese commander. He also contributed to the construction of ISS, including the Japanese experiment module Kibo. Wakata retired from the Japanese agency, JAXA, in March 2024.

“Japan intends to remain a leading nation in human space exploration post-ISS, and Japanese industry and academia are ready to play a central role in the commercial era,” Axiom Space said in the release. “Axiom Space Japan is how the company will meet that ambition with a long-term, on-the-ground presence.”

Houston investment firm closes $105M energy venture fund

seeing green

Houston-based investment firm Veriten has announced the initial close of its second flagship energy venture fund with more than $105 million in capital commitments.

Fund II will build on Veriten’s initial fund and aim to support “scalable technology solutions for energy, power and industrial applications,” according to a company news release.

"Our differentiated network, research-driven process, and first principles approach to investing are having an impact across multiple verticals including traditional energy, electrification, and industrial technology. Fund II builds on that platform,” John Sommers, partner, investments at Veriten, added in the release. “In this environment, the differentiator isn't capital – it's all about connectivity, deep sector expertise, and an economically-driven approach. As new technologies and approaches develop at breakneck speed, the need for more reliable, affordable energy and power continues to grow dramatically. The current backdrop accentuates the need for Veriten's solution."

Veriten is supported by over 50 strategic partnerships in the energy, power, industrial and technology sectors, including major players like Halliburton and Phillips 66.

"Veriten continues to build a differentiated platform at the intersection of energy, technology and industry expertise," Jeff Miller, chairman and CEO of Halliburton, said in the release. "We were early believers in the team and their ability to identify practical solutions to real challenges across the energy value chain. As all industries increasingly adopt digital tools, automation and AI-enabled technologies to improve performance and execution, we are proud to partner with Veriten again to help accelerate high-impact solutions across the broader energy landscape."

Veriten closed its debut fund, NexTen LP, of $85 million in committed capital in October 2023. It was launched in January 2022 by Maynard Holt, co-founder and former CEO of the energy investment bank Tudor, Pickering, Holt & Co.

It has invested in Houston-based AI-powered electricity analytics provider Amperon and led a $12 million Seed 2 funding round for Houston-based Helix Technologies to scale manufacturing of its energy-efficient commercial HVAC add-on earlier this year. In the past year it has contributed to funding rounds for San Francisco-based Armada and Calgary-based Veerum.

Veriten also named Nick Morriss as its new managing director earlier this month. Morriss most recently served as vice president of business development at next-generation nuclear technology company Natura Resources and spent nearly 20 years at NOV Inc.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

View All Listings